The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply
JAMA Pediatr
.
2018 May 1;172(5):494-495.
doi: 10.1001/jamapediatrics.2018.0038.
Authors
Kevin J Downes
1
2
3
,
Benjamin L Laskin
3
4
,
Brian T Fisher
1
2
3
5
Affiliations
1
Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
2
Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
3
Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.
4
Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
5
Department of Biostatistics and Epidemiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.
PMID:
29507935
DOI:
10.1001/jamapediatrics.2018.0038
No abstract available
Publication types
Letter
Comment
MeSH terms
Acute Kidney Injury*
Child
Child, Hospitalized
Humans
Piperacillin
Tazobactam
Vancomycin*
Substances
Vancomycin
Tazobactam
Piperacillin